ABS38: Add-on omalizumab significantly improves quality of life in patients with severe persistent allergic (IgE-mediated) asthma

INTRODUCTION: Patients with severe persistent allergic asthma experience frequent serious exacerbations and daily symptoms that diminish health-related quality of life (QoL). AIMS AND OBJECTIVES: To evaluate effects on QoL of add-on omalizumab, an anti-IgE therapy. Subjects and method: A pooled anal...

詳細記述

保存先:
書誌詳細
出版年:Prim Care Respir J
主要な著者: Price, D., Fox, H., Surrey, K., Reisner, C.
フォーマット: Artigo
言語:Inglês
出版事項: Nature Publishing Group 2006
主題:
Abstracts
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6730753/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pcrj.2006.04.137
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料